Genmab — Juli 2020

[E_L]

And we expect to get a new trade name, which will actually reflect both the efficacy and safety of the label. So we will get a new brand name associated with this. So I think this would be a different overall label and brand name for ofatumumab.

[E_L]

So- a lot of attention in that call on Ofa.

[E_L]

Kiadis announces publication in Blood highlighting proof-of-concept to enhance potency of anti-CD38 antibodies with Kiadis’ K-NK004, recently licensed by Sanofi https://www.globenewswire.com/news-release/2020/07/22/2065517/0/en/Kiadis-announces-publication-in-Blood-highlighting-proof-of-concept-to-enhance-potency-of-anti-CD38-antibodies-with-Kiadis-K-NK004-recently-licensed-by-Sanofi.html

[E_L]

we saw this article before, and the funny thing is that it is using Dara instead of Isa

[GeorgeBest]

Thanks for All the info E L

[Helge_LarsenPI-redaktør]

Ditto from me.

[E_L]

i had no choice GB, I was forced

[gentogen]

Thanks EL

[E_L]

New Teprotumumab trial - A Randomized, Double-Blind Multicenter Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) - https://clinicaltrials.gov/ct2/show/NCT04478994?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=07%2F20%2F2020&draw=2&rank=12

[Helge_LarsenPI-redaktør]

US Darzalex salg fra Symphony Health for juni USD 219.8M. Juni 22 arbejsdage, mod 20 i maj. Stigning på dagsbasis ca. 8%

[bikube]

Hvis man kan holde den stigningstakt, ser det da smukt ud.

[nohope]

"Problemet" er nok ROW.

[bikube]

Der var det jo en reduktion på prisen, der fik et negativt udslag. Det skulle jo nødigt gentage sig. Jeg blev da noget skuffet over, at ROW blev sat tilbage ift. U S salg.

[Helge_LarsenPI-redaktør]

De tidlige nedlukninger i Q2 i Europa må have påvirket ROW kraftigt i negativ retning.

[nohope]

Yep. Det kan også sagtens tænkes at der er en mindre effektueringsprocent af Symphony tallene end ellers pga corona.

[AaBforever]

Patienter med cancer får vel ikke mindre behov for medicin og behandling, selv under en coronakrise?

[gdn55]

Hvis der under en krise ikke er personale nok til at udfører behandlingerne, må der jo vælges. Hvad der udsættes kan bliver udsat.

[E_L]

As we continue our journey toward becoming a fully integrated biotech company, we welcome Brad Bailey as Genmab’s first US General Manager. Brad will lead the Genmab US market organization and build the US team to enable Commercialization success. #Genmabnews

[E_L]

Senior Vice President https://twitter.com/Genmab/status/1285935918575222784

[AaBforever]

Du mener at de bare får lov til at sejle deres egen sø?